Dasiglucagon Works for Kids; New Diabetes Dietary Guidelines; Post-COVID Thyroiditis

(MedPage Today) -- Dasiglucagon reduced the need for IV glucose by 55% versus placebo in a pediatric population with congenital hyperinsulinism, according to a second phase III clinical trial by Zealand Pharma. The American Diabetes Association...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news